Class Action Update for MDT, FLGT, and CMP: Levi & Korsinsky, LLP Reminding Investors of Class Action on behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / November 4, 2022 / Levi & Korsinsky, LLP announces that class action lawsuits have been initiated on behalf of the shareholders of the following publicly traded companies. Shareholders who are interested in serving as lead plaintiff have until the deadlines set for filing a petition in court. More details about the cases can be found at the links provided. There is no cost or obligation to you.

MDT contributors click here: https://www.zlk.com/pslra-1/medtronic-class-action-loss-submission-form?prid=33374&wire=1
Click here for FLGT contributors: https://www.zlk.com/pslra-1/fulgent-genetics-lawsuit-loss-submission-form?prid=33374&wire=1
CMP contributors click here: https://www.zlk.com/pslra-1/compass-minerals-loss-submission-form?prid=33374&wire=1

*Additional information below*

Levi & Korsinsky, LLP, Friday 4 November 2022 Press release image

Medtronic plc (NYSE: MDT)

This suit is on behalf of persons and entities that purchased or otherwise acquired Medtronic’s common stock between June 8, 2019 and May 25, 2022, inclusive.
Lead Plaintiff’s Deadline : November 7, 2022
To find out more, visit: https://www.zlk.com/pslra-1/medtronic-class-action-loss-submission-form?prid=33374&wire=1

According to the complaint, (1) Medtronic’s product quality control systems were inadequate; (ii) Medtronic fails to comply with numerous regulations relating to risk assessment, corrective and preventive actions, complaint handling, instrument recalls, and adverse event reporting; (3) these failures have increased the risks of investigation and regulatory action; (4) As a result of company misconduct, the FDA will delay approval of additional Medtronic MiniMed devices, including the MiniMed 780G; (5) such delays in product approvals, as well as the Company’s need to improve quality control systems, would adversely affect the Company’s financial performance and cause Medtronic to fall behind its competitors; and (6) as a result of the foregoing, the defendants’ statements about the company’s business, operations, and prospects lacked a reasonable basis.

Fulgent Genetics, Inc. (NASDAQ: FLGT)

FLGT sued on behalf of: Investors who bought March 22, 2019 – August 4, 2022
Lead Plaintiff’s Deadline : November 21, 2022
To find out more, visit: https://www.zlk.com/pslra-1/fulgent-genetics-lawsuit-loss-submission-form?prid=33374&wire=1

According to the complaint, during the study period, Fulgent Genetics, Inc. statements that are materially false and/or misleading and/or fail to disclose: in connection with laboratory tests, making or receiving remuneration in contravention of the Anti-Bribery Act and the Stark Act; (ii) Accordingly, Fulgent was likely to be subject to further legal and regulatory scrutiny; (iii) Fulgent’s revenue, in so far as it was derived from the foregoing unlawful conduct, is unsustainable; (iv) the foregoing, once disclosed, is likely to expose the company to significant financial and/or reputational damage; and (v) as a result, the Company’s general statements have been materially false and misleading at all relevant times.

Compass Minerals International, Inc. (NYSE: CMP)

This claim is on behalf of all purchasers of the common stock of Compass Minerals between October 31, 2017 and November 18, 2018 inclusive.
Lead Plaintiff’s Deadline : December 20 2022
To find out more, visit: https://www.zlk.com/pslra-1/compass-minerals-loss-submission-form?prid=33374&wire=1

According to the complaint, 1) costs at the company’s salt mine in Goodrich, Ontario were increasing rather than declining; 2) the defendants misrepresented the amount of salt that the company was able to produce at Goderich using continuous mining equipment and continuous transportation; 3) It was reasonably expected that the known and continuing shortfall in production experienced by the company would reduce its future operating income.

You have until the lead plaintiff deadlines to ask the court to appoint you as the lead plaintiff. Your ability to participate in any refund does not require that you act as lead claimant.

Levi & Korsinsky is a nationally recognized company with offices in New York, California, Connecticut and Washington, DC. The company’s attorneys have extensive experience and expertise in representing investors in securities litigations and have recovered hundreds of millions of dollars for aggrieved shareholders. Advertisement attorney. Previous results do not guarantee similar results.

Call:
Levi and Korsinsky, LLP
Joseph E. Levy, Esq.
Edward Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

source: Levi and Korsinsky, LLP

View the source version on accesswire.com:
https://www.accesswire.com/724048/CLASS-ACTION-UPDATE-for-MDT-FLGT-and-CMP-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of- Shareholders

Leave a Comment